Boehringer Ingelheim Pharmaceuticals, Inc.

[Not Yet Scheduled]
Boehringer Ingelheim is a world-leading, research-driven biopharmaceutical company. Making new and better medicines for patients is at the heart of what we do. Independent and family-owned, we have the freedom to pursue our long-term vision, identifying the health challenges of the future and targeting those areas of need where we can do the most good.
Our vision is powered by innovation. And our industry-leading investment in R&D drives this, with a portfolio that is anchored by more than 60 new medical entities, enabling the next generation of breakthrough medicines.
We realize even more scientific opportunities by leveraging the wealth of complementary expertise and skills across the global community of scientists to bring critical diversity to innovation. We believe that by working together we can learn more, do more and achieve more and accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Connecticut
Company HQ Country:
United States
Year Founded:
1885
Main Therapeutic Focus:
Lead Product in Development:
NA
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Head of US Bus. Dev. & Licensing
Boehringer Ingelheim Pharmaceuticals, Inc.